339 related articles for article (PubMed ID: 25926655)
1. Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.
Cerqueira C; Samperio Ventayol P; Vogeley C; Schelhaas M
J Virol; 2015 Jul; 89(14):7038-52. PubMed ID: 25926655
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.
Becker M; Greune L; Schmidt MA; Schelhaas M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593032
[TBL] [Abstract][Full Text] [Related]
3. Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry.
Bienkowska-Haba M; Williams C; Kim SM; Garcea RL; Sapp M
J Virol; 2012 Sep; 86(18):9875-87. PubMed ID: 22761365
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of the HPV16 Minor Capsid Protein L2 during Virion Morphogenesis Ablates the Requirement for Cellular Furin during De Novo Infection.
Cruz L; Biryukov J; Conway MJ; Meyers C
Viruses; 2015 Nov; 7(11):5813-30. PubMed ID: 26569287
[TBL] [Abstract][Full Text] [Related]
5. Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.
DiGiuseppe S; Keiffer TR; Bienkowska-Haba M; Luszczek W; Guion LG; Müller M; Sapp M
J Virol; 2015 Oct; 89(20):10442-52. PubMed ID: 26246568
[TBL] [Abstract][Full Text] [Related]
6. Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.
Bronnimann MP; Calton CM; Chiquette SF; Li S; Lu M; Chapman JA; Bratton KN; Schlegel AM; Campos SK
J Virol; 2016 Jul; 90(14):6224-6234. PubMed ID: 27122588
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.
Day PM; Weisberg AS; Thompson CD; Hughes MM; Pang YY; Lowy DR; Schiller JT
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092566
[TBL] [Abstract][Full Text] [Related]
9. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
Day PM; Thompson CD; Lowy DR; Schiller JT
J Virol; 2017 May; 91(10):. PubMed ID: 28250129
[TBL] [Abstract][Full Text] [Related]
10. The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network.
DiGiuseppe S; Bienkowska-Haba M; Hilbig L; Sapp M
Virology; 2014 Jun; 458-459():93-105. PubMed ID: 24928042
[TBL] [Abstract][Full Text] [Related]
11. Alpha-defensin HD5 inhibits furin cleavage of human papillomavirus 16 L2 to block infection.
Wiens ME; Smith JG
J Virol; 2015 Mar; 89(5):2866-74. PubMed ID: 25540379
[TBL] [Abstract][Full Text] [Related]
12. Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity.
Zhang W; Kazakov T; Popa A; DiMaio D
mBio; 2014 Sep; 5(5):e01777-14. PubMed ID: 25227470
[TBL] [Abstract][Full Text] [Related]
13. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
[TBL] [Abstract][Full Text] [Related]
14. Identification of a role for the trans-Golgi network in human papillomavirus 16 pseudovirus infection.
Day PM; Thompson CD; Schowalter RM; Lowy DR; Schiller JT
J Virol; 2013 Apr; 87(7):3862-70. PubMed ID: 23345514
[TBL] [Abstract][Full Text] [Related]
15. Target cell cyclophilins facilitate human papillomavirus type 16 infection.
Bienkowska-Haba M; Patel HD; Sapp M
PLoS Pathog; 2009 Jul; 5(7):e1000524. PubMed ID: 19629175
[TBL] [Abstract][Full Text] [Related]
16. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.
Woodham AW; Da Silva DM; Skeate JG; Raff AB; Ambroso MR; Brand HE; Isas JM; Langen R; Kast WM
PLoS One; 2012; 7(8):e43519. PubMed ID: 22927980
[TBL] [Abstract][Full Text] [Related]
17. Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16.
Richards KF; Bienkowska-Haba M; Dasgupta J; Chen XS; Sapp M
J Virol; 2013 Nov; 87(21):11426-37. PubMed ID: 23966387
[TBL] [Abstract][Full Text] [Related]
18. Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.
Yan H; Foo SS; Chen W; Yoo JS; Shin WJ; Wu C; Jung JU
mBio; 2019 Aug; 10(4):. PubMed ID: 31387913
[TBL] [Abstract][Full Text] [Related]
19. Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions.
Schäfer G; Graham LM; Lang DM; Blumenthal MJ; Bergant Marušič M; Katz AA
J Virol; 2017 Aug; 91(16):. PubMed ID: 28566373
[TBL] [Abstract][Full Text] [Related]
20. A Novel PDZ Domain Interaction Mediates the Binding between Human Papillomavirus 16 L2 and Sorting Nexin 27 and Modulates Virion Trafficking.
Pim D; Broniarczyk J; Bergant M; Playford MP; Banks L
J Virol; 2015 Oct; 89(20):10145-55. PubMed ID: 26202251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
